,,ii  #aah? ,,congress  #a/ ,session    
,s4 #dgf  ,,9 ,,! ,,s5ate ,,( ,,!       
,,unit$ ,,/ates  ,febru>y #af1 #bjbc,mr4
 ,m55dez 7= himself & ,mrs4 ,blackburn7 
introduc$ ! foll[+ bill2 :i* 0 read     
twice & ref]r$ to ! ,committee on       
,f9ance  ,a ,,bill  ,to am5d title ,,xi 
( ! ,social ,security ,act to protect   
access to g5etically t>get$ te*nologies4
  #a4 ,%ort title ,?is ,act may be cit$ 
z ! ,ma9ta9+ ,inve/m5ts 9 ,new          
,innovation ,act4  #b4 ,am5dm5t to      
def9ition ( qualify+ s+le s\rce drug    
,section #aaib7;e7 ( ! ,social ,security
 ,act 7#db ,u4,s4,c4 #acbj;f-#a7;e77 is 
am5d$-- 7#a7 9 p>agraph 7#a77;,a77ii71  
by ins]t+ 7or1 9 ! case ( an advanc$    
drug product 7z def9$ 9 p>agraph 7#d771 
#aa ye>s7 aft] #g ye>s2 &  7#b7 by add+ 
at ! end ! foll[+ new p>agraph3  7#d7   
,advanc$ drug product def9$ ,= purposes 
( p>agraph 7#a77;,a77ii71 ! t]m advanc$ 
drug product means a drug t incorporates
 or utilizes a g5etically t>get$        
te*nology 7z def9$ 9 section            

#ebi;,a7c77#b7 ( ! ,f$]al ,food1 ,drug1 
& ,cosmetic ,act7 t may result 9 !      
modulation 7includ+ suppression1        
up-regulation1 or activation7 ( !       
function ( a g5e or its associat$ g5e   
product4  4